For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
The Research Surgeon executes established surgical and technical procedures according to Standard Operating Procedures (SOP). This surgeon is responsible for perioperative preparation in addition to training technical staff on routine care for animals encompassing surgical and/or advanced techniques. The Research Surgeon works in concert with other research surgeon,s research associates, and veterinary, scientific, and technical personnel to support established animal models in addition to other models in the midst of optimization or development.
- To adhere to Good Laboratory Practice (GLP) regulations and organizational Standard Operating Procedure (SOPs).
- To perform study specific surgeries in a wide variety of laboratory animal species.
- Offer surgical and technical support on studies (e.g.: surgery room preparation, sterile assistant, perform advances techniques) including complete peri-operative care and oversight for the animals.
- Work closely with the other surgeons in the development of new procedures, refinements and/or by supporting current procedures.
- To help support different departments by providing technical expertise.
- Ensure adequate training of technical personnel with subjects related to surgery and/or basic techniques as delegated.
- Perform follow-ups on animals that underwent surgery to ensure their well-being whilst appropriate surgical and/or veterinary staff.
- Perform all other related duties as assigned.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 14,000 employees within 80 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2018, revenue increased by 22% to $2.27 billion from $1.86 billion in 2017.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2018.